Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
77M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
+1.28M
-
Total reported value, excl. options
-
$121M
-
Value change
-
+$12.5M
-
Number of buys
-
34
-
Number of sells
-
-22
-
Price
-
$9.11
Significant Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q2 2017
65 filings reported holding CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value as of Q2 2017.
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
of 77M outstanding shares and own 17.26% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (2.88M shares), Cormorant Asset Management, LLC (1.94M shares), BlackRock Inc. (1.3M shares), FMR LLC (981K shares), Rock Springs Capital Management LP (935K shares), Hillhouse Capital Management, Ltd. (900K shares), VANGUARD GROUP INC (702K shares), PERCEPTIVE ADVISORS LLC (620K shares), AWM Investment Company, Inc. (401K shares), and FIRST MANHATTAN CO (350K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.